Skip to main content
Log in

Treatment Strategy for Post-hepatectomy Recurrent Hepatocellular Carcinoma Within the Milan Criteria: Repeat Resection, Local Ablative Therapy or Transarterial Chemoembolization?

  • Original Article
  • Published:
Indian Journal of Surgery Aims and scope Submit manuscript

Abstract

The results of treatment for early stage recurrent hepatocellular carcinoma (HCC) remain controversial. This study aimed to analyze the clinical outcomes of recurrent HCC within the Milan criteria following different treatment modalities except liver transplantation. From January 2006 to December 2016, 272 consecutive HCC patients who developed intrahepatic recurrence after hepatectomy that satisfied the Milan criteria and Child–Pugh class A or B liver function were retrospectively enrolled. The outcomes of repeat resection (RR), local ablative therapy (LAT), or transarterial chemoembolization (TACE) were reported, and the prognostic factors of survival were investigated. Among the 272 patients, 136 (50.0%), 71 (26.1%), and 65 (23.9%) received TACE, LAT, and RR treatments, respectively. Treatment-related complications were 9.5%, 11.3%, and 10.7%, respectively, in the three groups. No patient died of treatment-related complication. The 1-, 3-, and 5-year overall survival rates after recurrence were 95.0%, 54.2%, and 45.8%, respectively, in the RR group; 86.6%, 51.7%, and 42.4%, respectively, in the LAT group; and 77.2%, 46.5%, and 38.4%, respectively, in the TACE group. On multivariate analysis, three independent factors related to survival after recurrences were identified. A single tumor nodule and AFP < 200 ng/mL predicted better survival, while a disease-free interval ≤ 1 year was associated with poor outcomes. RR and LAT could achieve good survival outcomes in well-selected patients with recurrent HCC within the Milan criteria, while TACE was the main form of treatment when curative therapy was not considered feasible and the clinical outcomes were satisfactory.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Data Availability

Clinical data of the patients is attached as the supplementary material.

Code Availability

Not applicable.

References

  1. Zhong JH, Ke Y, Gong WF et al (2014) Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma. Ann Surg 260:329–340

    Article  Google Scholar 

  2. Chan DL, Alzahrani NA, Morris DL et al (2014) Systematic review of efficacy and outcomes of salvage liver transplantation after primary hepatic resection for hepatocellular carcinoma. J Gastroenterol Hepatol 29:31–41

    Article  Google Scholar 

  3. Guo Y, Tan EK, Krishnamoorthy TL et al (2019) Outcomes of salvage liver transplant for recurrent hepatocellular carcinoma: a comparison with primary liver transplant. Ann Hepatobiliary Pancreat Surg 23:1–7

    Article  CAS  PubMed Central  Google Scholar 

  4. Hu Z, Wang W, Li Z et al (2012) Recipient outcomes of salvage liver transplantation versus primary liver transplantation: a systematic review and meta-analysis. Liver Transpl 18:1316–1323

    Article  Google Scholar 

  5. Lim C, Shinkawa H, Hasegawa K et al (2017) Salvage liver transplantation or repeat hepatectomy for recurrent hepatocellular carcinoma: an intent-to-treat analysis. Liver Transpl 23:1553–1563

    Article  Google Scholar 

  6. Wang HL, Mo DC, Zhong JH et al (2019) Systematic review of treatment strategy for recurrent hepatocellular carcinoma. Salvage liver transplantation or curative locoregional therapy. Medicine (Baltimore) 98:e14498

    Article  Google Scholar 

  7. Fuks D, Dokmak S, Paradis V et al (2012) Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis. Hepatology 55:132–140

    Article  Google Scholar 

  8. Liu F, Wei Y, Wang W et al (2012) Salvage liver transplantation for recurrent hepatocellular carcinoma within UCSF criteria after liver resection. PLOS ONE 7:e48932

    Article  CAS  PubMed Central  Google Scholar 

  9. Wu L, Hu A, Tam N et al (2012) Salvage liver transplantation for patients with recurrent hepatocellular carcinoma after curative resection. PLOS ONE 7:e41820

    Article  CAS  PubMed Central  Google Scholar 

  10. Wen T, Jin C, Facciorusso A et al (2018) Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus. Hepatobiliary Surg Nutr 7:353–371

    Article  PubMed Central  Google Scholar 

  11. Yagi R, Midorikawa Y, Moriguchi M et al (2018) Liver resection for recurrent hepatocellular carcinoma to improve survivability: a proposal of indication criteria. Surgery 163:1250–1256

    Article  Google Scholar 

  12. Meniconi RL, Komatsu S, Perdigao F et al (2015) Recurrent hepatocellular carcinoma: a Western strategy that emphasizes the impact of pathologic profile of the first resection. Surgery 157:454–462

    Article  Google Scholar 

  13. Li M, Wang Z, Cao J et al (2019) Risk factors and prognosis of patients with recurrent hepatocellular carcinoma who undergo liver re-resections. Eur J Surg Oncol 45:1684–1690

    Article  Google Scholar 

  14. Chan AC, Poon RT, Cheung TT et al (2012) Survival analysis of re-resection versus radiofrequency ablation for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. World J Surg 36:151–156

    Article  Google Scholar 

  15. Liang HH, Chen MS, Peng ZW et al (2008) Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma: a retrospective study. Ann Surg Oncol 15:3484–3493

    Article  Google Scholar 

  16. Song KD, Lim HK, Rhim H et al (2015) Repeated hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma after hepatic resection: a propensity score matching study. Radiology 275:599–608

    Article  Google Scholar 

  17. Jin YJ, Lee JW, Lee OH et al (2014) Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion. J Gastroenterol Hepatol 29:1056–1064

    Article  Google Scholar 

  18. Koh PS, Chan ACY, Cheung TT et al (2016) Efficacy of radiofrequency ablation compared with transarterial chemoembolization for the treatment of recurrent hepatocellular carcinoma: a comparative survival analysis. HPB (Oxf) 18:72–78

    Article  Google Scholar 

  19. Xiao H, Chen ZB, Jin HL et al (2019) Treatment selection of recurrent hepatocellular carcinoma with microvascular invasion at the initial hepatectomy. Am J Transl Res 11:1864–1875

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Lee JM, Yoon JH, Joo I et al (2012) Recent advances in CT and MR imaging for evaluation of hepatocellular carcinoma. Liver Cancer 1:22–40

    Article  PubMed Central  Google Scholar 

  21. Kircher A, Bongartz G, Merkle EM et al (2014) Rational imaging of hepatocellular carcinoma: the challenge of multimodal diagnostic criteria. Radiologe 54:664–672

    Article  CAS  Google Scholar 

  22. Bruix J, Sherman M (2011) American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022

    Article  Google Scholar 

  23. Guo WX, Zhai B, Lai EC et al (2010) Percutaneous radiofrequency ablation versus partial hepatectomy for multicentric small hepatocellular carcinomas: a nonrandomized comparative study. World J Surg 34:2671–2676

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

All the authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Xiaoliang Yang, Xingwu Zhu, and Maixuan Qiu. The first draft of the manuscript was written by Jing Li and Liang Huang, and all the authors commented on the previous versions of the manuscript. All the authors read and approved the final manuscript.

Corresponding author

Correspondence to Shaohua Wei.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 379 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, J., Yang, X., Huang, L. et al. Treatment Strategy for Post-hepatectomy Recurrent Hepatocellular Carcinoma Within the Milan Criteria: Repeat Resection, Local Ablative Therapy or Transarterial Chemoembolization?. Indian J Surg 84 (Suppl 2), 384–389 (2022). https://doi.org/10.1007/s12262-022-03343-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12262-022-03343-1

Keywords

Navigation